Search - tctmd.com

Displaying 1 - 20 of 182

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular News and Features for 2016

Shelley Wood

December 29, 2016

News Opinion Editor's Corner

TCTMD 年十大热门新闻、博客和焦点

Shelley Wood

December 29, 2016

News Daily News

Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label?

Yael L. Maxwell

December 23, 2016

News Conference News TCT 2016

RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent

Michael O'Riordan

November 08, 2016

News Conference News TCT 2016

RIBS VI：Absorb BVS 支架内再狭窄方面安全，但没有好过 Xience 金属支架

Michael O'Riordan

November 08, 2016

Presentation TCT 2016

Selective or Routine Intracoronary Imaging for BVS Implantation? Pro-Routine!

Presenter: Jonathan M. Hill, Christoph K. Naber, Ricardo A. Costa

November 01, 2016

Presentation TCT 2016

Flash Debate: Selective or Routine Intracoronary Imaging for BVS Implantation? Pro-Selective!

Presenter: Jonathan M. Hill, Christoph K. Naber, Joanna J. Wykrzykowska

November 01, 2016

Presentation TCT 2016

Highlights (and My Interpretations) From: Absorb BVS - ABSORB II and ABSORB China (2-3 Year Results)

Presenter: Philip M. Urban, Stephen G. Worthley, Stephen G. Ellis

November 01, 2016

Presentation TCT 2016

Impact of Small Vessels on BVS Outcomes and the Role of Target Vessel Mismatch

Presenter: Stephen G. Ellis, Patrick W. Serruys

November 01, 2016

Presentation TCT 2016

Duration of DAPT Therapy With Contemporary DES (Including BVS)

Presenter: Alejandro Cherro, Anibal A. Damonte, Alfredo E. Rodriguez, Gustavo A Samaja

October 31, 2016

Presentation TCT 2016

The Great Absorb Debate: Is Absorb Ready To Be Used In Most Patients And Lesions? No Short-Term Data Is Borderline, Procedures Are More Costly And Complex, And Long-Term Data Is Scant Best To Wait!

Presenter: Stephen G. Ellis, Corrado Tamburino, Daniel I. Simon

October 31, 2016

Presentation TCT 2016

The Great Absorb Debate: Is Absorb Ready To Be Used In Most Patients And Lesions? Yes With Proper Technique And Planning, Nearly All PCI Patients Can Benefit From BVS!

Presenter: Stephen G. Ellis, Corrado Tamburino, Massimo Napodano

October 31, 2016

Presentation TCT 2016

Outcome Registries VII: IT-DISAPPEARS

Presenter: Stephen G. Ellis, Corrado Tamburino, Anna Sonia Petronio

October 31, 2016

Presentation TCT 2016

Outcome Registries VI: France ABSORB

Presenter: Stephen G. Ellis, Corrado Tamburino, Didier Carrié

October 31, 2016

Presentation TCT 2016

Outcome Registries V: New Insights From GHOST

Presenter: Stephen G. Ellis, Corrado Tamburino

October 31, 2016

Presentation TCT 2016

Outcome Registries IV: The UK Absorb Registry

Presenter: Stephen G. Ellis, Corrado Tamburino, Andreas Baumbach

October 31, 2016

Presentation TCT 2016

Outcome Registries III: 2-Year Results From ASSURE

Presenter: Stephen G. Ellis, Corrado Tamburino, Detlef G. Mathey

October 31, 2016

Presentation TCT 2016

Outcome Registries II: Long-term Outcomes From ABSORB EXPAND and STEMI First

Presenter: Stephen G. Ellis, Corrado Tamburino, Robert-Jan van Geuns

October 31, 2016

Presentation TCT 2016

Outcome Registries I: Extended Results From ABSORB EXTEND

Presenter: Stephen G. Ellis, Corrado Tamburino, Alexandre Abizaid

October 31, 2016

Presentation TCT 2016

ABSORB China Clinical Outcomes at 2 Years

Presenter: Stephen G. Ellis, Corrado Tamburino, Runlin Gao

October 31, 2016

Advertisement

TCTMD’s Top 10 Most Popular News and Features for 2016

TCTMD 年十大热门新闻、博客和焦点

Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label?

RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent

RIBS VI：Absorb BVS 支架内再狭窄方面安全，但没有好过 Xience 金属支架

Selective or Routine Intracoronary Imaging for BVS Implantation? Pro-Routine!

Flash Debate: Selective or Routine Intracoronary Imaging for BVS Implantation? Pro-Selective!

Highlights (and My Interpretations) From: Absorb BVS - ABSORB II and ABSORB China (2-3 Year Results)

Impact of Small Vessels on BVS Outcomes and the Role of Target Vessel Mismatch

Duration of DAPT Therapy With Contemporary DES (Including BVS)

The Great Absorb Debate: Is Absorb Ready To Be Used In Most Patients And Lesions? No Short-Term Data Is Borderline, Procedures Are More Costly And Complex, And Long-Term Data Is Scant Best To Wait!

The Great Absorb Debate: Is Absorb Ready To Be Used In Most Patients And Lesions? Yes With Proper Technique And Planning, Nearly All PCI Patients Can Benefit From BVS!

Outcome Registries VII: IT-DISAPPEARS

Outcome Registries VI: France ABSORB

Outcome Registries V: New Insights From GHOST

Outcome Registries IV: The UK Absorb Registry

Outcome Registries III: 2-Year Results From ASSURE

Outcome Registries II: Long-term Outcomes From ABSORB EXPAND and STEMI First

Outcome Registries I: Extended Results From ABSORB EXTEND

ABSORB China Clinical Outcomes at 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content